Presence of anti-transcriptional intermediary factor-1 gamma antibodies in a dermatomyositis patient with retroperitoneal cancer of unknown primary site-Reference-Cited by-同舟云学术

Presence of anti-transcriptional intermediary factor-1 gamma antibodies in a dermatomyositis patient with retroperitoneal cancer of unknown primary site

Published:2020-07-09 Issue:1 Volume:5 Page:62-68
ISSN:2472-5625
Container-title:Modern Rheumatology Case Reports
language:en
Short-container-title:Modern Rheumatology Case Reports

Author:

Hori Hiroshi¹^ORCID,Ozeki Yusuke¹,Kobashigawa Tsuyoshi²^ORCID,Futsuhara Kazusige³,Tanaka Akira⁴,Watanabe Eri²,Yabe Hiroki²,Yago Toru⁵,Fukuchi Takahiko¹^ORCID,Sugawara Hitoshi¹^ORCID,Kotake Shigeru²

Affiliation:

1. Division of General Medicine, Department of Comprehensive Medicine 1, Saitama Medical Center, Jichi Medical University, Saitama, Japan

2. Division of Rheumatology, Department of Comprehensive Medicine 1, Saitama Medical Center, Jichi Medical University, Saitama, Japan

3. Divison of Surgery, Department of Comprehensive Medicine 2, Saitama Medical Center, Jichi Medical University, Saitama, Japan

4. Division of Pathology, Department of Comprehensive Medicine 2, Saitama Medical Center, Jichi Medical University, Saitama, Japan

5. Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/24725625.2020.1789302

Reference22 articles.

1. Prevalence and incidence of polymyositis and dermatomyositis in Japan

2. Idiopathic inflammatory myopathies

3. Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review

4. Polymyositis/dermatomyositis and Malignancy Risk: A Metaanalysis Study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paraneoplastic anti-TIF1-gamma-positive dermatomyositis as expression of cervical squamous cell carcinoma recurrence;BMJ Case Reports;2024-01

2. Clinical features of dermatomyositis patients with anti-TIF1 antibodies: A case based comprehensive review;Autoimmunity Reviews;2023-12